Eric J. Carlson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eric J. Carlson has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Reid Doe
Oregon Health and Science University
25 shared publications - Amy S. Farrell
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
25 shared publications - Andrew C. Adey
Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA
25 shared publications - Andrew J. Fields
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon
25 shared publications - Anupriya Agarwal
Division of Oncological Sciences, Oregon Health & Science University, United States
25 shared publications - Arslan Amer
Cancer Early Detection Advanced Research (CEDAR) Center, Oregon Health & Science University, Portland, Oregon
25 shared publications
Latest Publications
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 6 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
DESeq2 comparing DMSO untreated vs TGFβ treated
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 6 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
DESeq2 comparing DMSO untreated vs TGFβ treated
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
PIN1 loss impacts KPC pancreas weight and fibroblast ⍺SMA expression
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
PIN1 loss impacts KPC pancreas weight and fibroblast ⍺SMA expression
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 2 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
DESeq2 for shSCR PSCs comparing TGF-β treated vs untreated
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 2 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
DESeq2 for shSCR PSCs comparing TGF-β treated vs untreated
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 4 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
CAF marker FPKMs in knockdown samples
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 4 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
CAF marker FPKMs in knockdown samples
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 11 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Secreted Signals overlap with DEGs (FPKMs)
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 11 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Secreted Signals overlap with DEGs (FPKMs)
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 5 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
RNA-seq on inhibitor samples, FPKMs all protein coding genes
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 5 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
RNA-seq on inhibitor samples, FPKMs all protein coding genes
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
PIN1 knockdown or inhibition impacts the transcriptional response to TGFβ
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
PIN1 knockdown or inhibition impacts the transcriptional response to TGFβ
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Data from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
The prolyl isomerase PIN1 is overexpressed in cancer and contributes to cancer cell–intrinsic phenotypes, including proliferation and migration. However, PIN1 may also function in stromal cells within the tumor microenvironment. In this study, we showed that PIN1 is a critical regulator of pancreatic stellate cell (PSC) state at baseline and in response to the myofibroblast-activating factor TGFβ. Loss or inhibition of PIN1 altered the epigenetic and transcriptional responses of PSCs to TGFβ, preventing PSC differentiation to a myofibroblast state and altering expression of secreted matrix proteins and signaling molecules. Consistent with inhibition of the TGFβ response, low fibroblast PIN1 expression in mouse and human pancreatic ductal adenocarcinoma correlated with low expression of αSMA, a marker of myofibroblast activation. Decreased PIN1 expression at baseline also altered paracrine hepatocyte growth factor (HGF) signaling from fibroblasts to tumor cells. PSCs with low PIN1 expression displayed reduced expression and secretion of HGF, resulting in an attenuation of c-MET receptor phosphorylation and signaling in nearby cancer cells. In allograft models, host PIN1 was critical for normal growth of a subset of pancreatic cancer cell lines that are responsive to HGF signaling. Through the identification of changes to fibroblast activation state and cross-talk following PIN1 loss or inhibition, these data suggest that systemic targeting of PIN1 will suppress the protumorigenic pancreatic ductal adenocarcinoma microenvironment and may differentially affect heterogeneous patient populations.Significance:PIN1 plays a critical role in the response of pancreatic stellate cells to TGFβ and can be targeted to attenuate myofibroblast activation and protumor cross-talk to suppress pancreatic cancer progression.
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
The prolyl isomerase PIN1 is overexpressed in cancer and contributes to cancer cell–intrinsic phenotypes, including proliferation and migration. However, PIN1 may also function in stromal cells within the tumor microenvironment. In this study, we showed that PIN1 is a critical regulator of pancreatic stellate cell (PSC) state at baseline and in response to the myofibroblast-activating factor TGFβ. Loss or inhibition of PIN1 altered the epigenetic and transcriptional responses of PSCs to TGFβ, preventing PSC differentiation to a myofibroblast state and altering expression of secreted matrix proteins and signaling molecules. Consistent with inhibition of the TGFβ response, low fibroblast PIN1 expression in mouse and human pancreatic ductal adenocarcinoma correlated with low expression of αSMA, a marker of myofibroblast activation. Decreased PIN1 expression at baseline also altered paracrine hepatocyte growth factor (HGF) signaling from fibroblasts to tumor cells. PSCs with low PIN1 expression displayed reduced expression and secretion of HGF, resulting in an attenuation of c-MET receptor phosphorylation and signaling in nearby cancer cells. In allograft models, host PIN1 was critical for normal growth of a subset of pancreatic cancer cell lines that are responsive to HGF signaling. Through the identification of changes to fibroblast activation state and cross-talk following PIN1 loss or inhibition, these data suggest that systemic targeting of PIN1 will suppress the protumorigenic pancreatic ductal adenocarcinoma microenvironment and may differentially affect heterogeneous patient populations.Significance:PIN1 plays a critical role in the response of pancreatic stellate cells to TGFβ and can be targeted to attenuate myofibroblast activation and protumor cross-talk to suppress pancreatic cancer progression.
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 12 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Motif analysis from sciATAC-seq
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 12 from The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Motif analysis from sciATAC-seq